Ibusal (Ibuprofen)

Ibuprofen non‑selectively inhibits the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which are required for the conversion of arachidonic acid to prostaglandins. By lowering prostaglandin production, it reduces the sensitisation of nerve endings to pain, diminishes fever‑inducing signals in the hypothalamus, and limits inflammation in affected tissues.

The appropriate dose of Ibusal is determined by the prescribing clinician based on the patient’s age, weight, the severity of symptoms, and any relevant medical conditions. Dosage recommendations follow national guidelines for ibuprofen, and patients should follow the prescriber’s instructions and the product label.

Safety of ibuprofen in pregnancy and lactation depends on the trimester and individual risk factors. Generally, ibuprofen is avoided in the third trimester because of possible fetal complications, and caution is advised during the first two trimesters. Breastfeeding mothers should consult a healthcare professional before use.

To request Ibusal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibusal (ibuprofen) shares the core anti‑inflammatory and analgesic mechanisms of other non‑steroidal anti‑inflammatory drugs such as naproxen or diclofenac, but it has a relatively short half‑life and a well‑established safety profile at recommended doses. Choice of NSAID often depends on individual tolerability, dosing frequency and specific clinical considerations.

Ibusal should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Ibusal is taken orally, usually with a full glass of water. It may be taken with or without food; however, taking it with food or milk can help minimise gastrointestinal discomfort. The tablet should be swallowed whole and not chewed or crushed unless directed by a healthcare professional.

The most serious adverse events linked to ibuprofen include gastrointestinal bleeding or ulceration, acute kidney injury, and severe hypersensitivity reactions such as anaphylaxis. Patients with a history of ulcer disease, renal impairment, or known NSAID allergy should be monitored closely or avoid use.

Ibusal should be avoided by individuals with a documented hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients with severe renal or hepatic impairment, and anyone who has experienced a serious cardiovascular event while using NSAIDs. Consultation with a healthcare provider is essential before starting therapy.